NCT01194219
- Conditions
- Plaque Psoriasis
- Locations
-
Not specified
Clinical trial condition
Plaque Psoriasis
Explore clinical trials studying Plaque Psoriasis. Study availability and eligibility vary by location and protocol.
298 public trials
24 recruiting studies
Plaque Psoriasis trial results
- Conditions
- Plaque Psoriasis
- Locations
-
Not specified
NCT03930186
- Conditions
- Plaque Psoriasis
- Locations
-
- Research Site Erlangen, Germany
- Research Site Fukuoka, Japan
- Research Site Fukuoka-shi, Fukuoka, Fukuoka, Japan
- Research Site Fukuoka-shi, Fukuoka, Fukuoka, Japan
NCT04398732
- Conditions
- Plaque Psoriasis
- Locations
-
- Pfizer Baghdad, Iraq
NCT04428411
- Conditions
- Plaque Psoriasis
- Locations
-
- Pfizer Baghdad, Iraq
NCT03589885
- Conditions
- Plaque Psoriasis
- Locations
-
- Novartis Investigative Site Miami, Florida, United States
- Novartis Investigative Site Marietta, Georgia, United States
- Novartis Investigative Site Saint Joseph, Missouri, United States
- Novartis Investigative Site Verona, New Jersey, United States
NCT03073200
- Conditions
- Plaque Psoriasis
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Tien Q. Nguyen, MD inc. DBA First OC Dermatology Fountain Valley, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
- Olympian Clinical Research Clearwater, Florida, United States
NCT03832738
- Conditions
- Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
- Locations
-
- Clinical Science Institute Santa Monica, California, United States
- Advanced Dermatology and Skin Cancer Specialists Temecula, California, United States
- Dawes Fretzin Clinical Research Group, LLC Indianapolis, Indiana, United States
- Central Sooner Research Norman, Oklahoma, United States
NCT02346240
- Conditions
- Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
- Locations
-
- Ps0003 317 Mobile, Alabama, United States
- Ps0003 306 Little Rock, Arkansas, United States
- Ps0003 301 Beverly Hills, California, United States
- Ps0003 307 Los Angeles, California, United States
Completed
A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque Psoriasis
NCT03364309
- Conditions
- Pathological Conditions, Signs and Symptoms, Plaque Psoriasis, Pruritus, +4 more
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
- Peking University Third Hospital Beijing, Beijing Municipality, China
- Guangdong Province People's Hospital Guangzhou, Guangdong, China
- The Second Xiangya Hospital of Central South University Changsha, Hunan, China